A

Abbisko Cayman
2256

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$6.88B
EV
HK$4.77B
Shares Outstanding
675.81M
Beta
1.30

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$10.58
P/E 2025E
-
P/Revenue 2025E
12.03x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Abbisko Cayman Limited

gainify

A

Abbisko Cayman Limited

2256

Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule oncology therapies in Mainland China. The company’s product candidates are primarily small molecules that focus on small molecule precision o...

Sector

Healthcare

Industry

Biotechnology

CEO

Xu, Yao-Chang

Employees

281

IPO Date

2021-10-13

Headquarters

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.